未登录

谢

谢虹 (Hong Xie)

Tianjin Medical University

H指数:22

被引数:1,704

个人简介

现任天津医科大学基础医学院病原生物学系副教授。1990年至1994年在南开大学生命科学院微生物学系获理学学士学位，2008年至2009年在瑞典卡罗林斯卡医学院分子医学与外科学系完成博士研究生预备课程，2009年至2014年获该校肿瘤病理系哲学博士学位。1994年至2002年任江中制药厂北京江中药物研究所助理工程师/工程师，2002年至2007年任北京宝赛生物技术有限公司技术总工，2007年任北京科美生物技术有限公司工程师，2014年至2015年任瑞典卡洛林斯卡医学院肿瘤病理学系博士后，2015年至2018年任天津医科大学基础医学院病原生物学系讲师，2019年起任现职。2018年获天津医科大学优秀班导师。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

miR-150-5p Regulates Merkel Cell Carcinoma Progression by Targeting FTO That Stabilizes CTNNB1 via m6A Modification

miR-150-5p通过靶向FTO，经由m6A修饰稳定CTNNB1来调控梅克尔细胞癌的进展。

Molecular Carcinogenesis

IF3.2

2025-08-220

PRE

Organ-specific immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitors

接受免疫检查点抑制剂的癌症患者的器官特异性免疫相关不良事件和预后

IF3.4

2025-01-241

OAAI

Dissociated response and treatment outcome with immune checkpoint blockade in advanced cancer

免疫检查点阻断在晚期癌症中的分离反应和治疗结果

SCIENTIFIC REPORTS

IF3.9

2024-12-300

OAAI

Characteristics of Spatial and Temporal Variation in Drought in the Sichuan Basin from 1963 to 2022

IF3.3

2024-09-272

OA

miR-27a-3p upregulation by p65 facilitates cervical tumorigenesis by increasing TAB3 expression and is involved in the positive feedback loop of NF-κB signaling

ONCOLOGY REPORTS

IF3.9

2023-05-101

OAAI

RETRACTION: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells (Retraction of Vol 48, Pg 117, 2019)

IF10.8

2021-10-010

OA

RETRACTION: miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells (Retraction of Vol 17, art no 36, 2017)

CANCER CELL INTERNATIONAL

IF6

2021-05-101

OAAI

miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells (vol 17, 36, 2017)

CANCER CELL INTERNATIONAL

IF6

2020-07-172

OAAI

The effect of magnetic stimulation on differentiation of human induced pluripotent stem cells into neuron

磁刺激对人诱导多能干细胞向神经元分化的影响

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2020-01-0914

PREAI

RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells (Retracted article. See vol. 72, 2021)

撤回: HBV编码的miR-2通过下调TRIM35但上调RAN在肝癌细胞中充当癌基因 (撤回的文章。见第72卷，2021)

IF10.8

2019-10-0130

OAAI

Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes

Merkel细胞多瘤病毒癌蛋白诱导抑制多个自噬基因的microrna

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2019-06-2023

OAAI

MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells

JOURNAL OF CANCER

IF3.2

2019-01-0111

OAAI

Functional role of merkel cell polyomavirus T-antigen regulated microRNAs in merkel cell carcinoma

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2018-05-010

OAAI

Thrombin-reduced miR-27b attenuates platelet angiogenic activities in vitro via enhancing platelet synthesis of anti-angiogenic thrombospondin-1

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2018-04-0126

OAAI

miR-377-3p drives malignancy characteristics via upregulating GSK-3 expression and activating NF-B pathway in hCRC cells

miR-377-3p通过上调GSK-3表达和激活nf-κb途径驱动hCRC细胞的恶性特征

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

2017-10-2340

PREAI

Intermediate-Term Outcomes and Complications of Long Segment Urethroplasty with Lingual Mucosa Grafts

JOURNAL OF UROLOGY

IF6.8

2017-08-0120

PREAI

RETRACTED: miR-484 suppresses proliferation and epithelial-mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells (Retracted Article)

CANCER CELL INTERNATIONAL

IF6

2017-03-0763

OAAI

Upregulation of kazrin F by miR-186 suppresses apoptosis but promotes epithelial-mesenchymal transition to contribute to malignancy in human cervical cancer cells

CHINESE JOURNAL OF CANCER RESEARCH

IF6.3

2017-01-0121

OA

miR-429 is involved in regulation of NF-κBactivity by targeting IKKβ and suppresses oncogenic activity in cervical cancer cells

IF3

2016-12-2049

OAAI

One-stage dorsal lingual mucosal graft urethroplasty for the treatment of failed hypospadias repair

ASIAN JOURNAL OF ANDROLOGY

IF2.7

2016-01-016

OAAI